The Celiac Disease Foundation Prize for Excellence in Celiac Disease Research recognizes investigators whose research is judged to have made a significant contribution to the field of celiac disease research. The Prize is awarded annually in the amount of $25,000 USD and is presented at the Annual Research Symposium sponsored by the Celiac Disease Foundation. 

Eligibility 

The Prize Laureate must be an individual whose research has made a significant contribution to the field of celiac disease and must be living at the time of award and able to present their research at the Celiac Disease Foundation Annual Research Symposium. The Prize is awarded solely on the significance of clinical, translational, or transformative research and its impact on celiac disease patients, and is awarded based on actual research contributions, and not for the establishment or development of a research institution or research infrastructure.  

To avoid the appearance of conflict of interest, employees of for-profit pharmaceutical or biotechnology companies will not be eligible. Prior Prize Laureates are not eligible for nomination, but prior nominees who were not selected in previous award cycles may be nominated in subsequent award cycles with no limit. Previous recipients of the Warren Prize for Excellence in Celiac Disease Research or the Maki Celiac Disease Tampere Prize are not eligible for nomination. English is the official language for the Prize administration, including the nomination process, deliberations, and associated materials as described herein.  

Nominations 

Nominations for the Prize Laureate are made by members of the Selection Jury. The Prize is not open to application, although Jurors may choose Nominees recommended by the celiac disease community at large through an open call for Letters of Recommendation for Nominations. Jurors are asked not to discuss or confer regarding potential Nominees or actual nominations with other Jurors prior to or outside of official deliberations. A Nominee may be nominated by multiple Jurors, and Jurors will not be asked to make an alternate nomination in the case of multiple nominations from any other Juror(s).  

The Celiac Disease Foundation will make an open call for Letters of Recommendation for Nominations of no more than 500 words to give the community at-large an opportunity to suggest Nominees for the Prize. Only those Letters submitted during the timeframe specified by the Celiac Disease Foundation will be considered, and the Foundation will compile all Letters of Recommendation and distribute them to the Selection Jury. Jurors may review Letters of Recommendation for Nominations at their discretion and are not obligated to take Letters of Recommendation for Nominations into account in making their nominations. Any person writing a Letter of Recommendation for Nominations is prohibited from making unsolicited contact with Jurors. Violating this rule will result in the withdrawal of the Letter of Recommendation for Nomination. The Celiac Disease Foundation will compile a Nomination Dossier for each Nominee that will be circulated to the Jurors for review prior to deliberations, consisting of:  

  1. Nomination Statement of no more than 500 words, written by the Juror making the nomination and addressing the selection criteria  
  2. Nominee’s curriculum vitae with career and publication highlights 

Selection Process 

A quorum of all five Jurors must be present for the entirety of deliberations. Jurors may not be presented as Nominees during their service on the Selection Jury. The deliberations will be confidential and closed. Only Selection Jury members and representatives of the Celiac Disease Foundation may be present during the deliberations. In addition, names of all unselected Nominees shall remain confidential. The Prize Laureate will be selected during deliberations that may last for no longer than one day, with presentations to support each Nominee that will be made by the respective nominating Juror.  

The slate of Nominees will be reduced by successive rounds of elimination. Jurors will vote by secret ballot on rounds. After each round, one or more Nominees will be eliminated, with cut points determined by a Chairperson. The Chairperson will announce the names of the remaining Nominees. Further discussion may follow for each round at the discretion of the Chairperson, including the time allotted for the discussion. As Nominees are eliminated, the Jury will continue voting until two Nominees remain. The final choice between those two Nominees will be made by majority vote. The Nominee receiving the majority vote will be declared the Prize Laureate.  

Should the Jurors reach a unanimous decision at any point during the deliberations, Jurors can motion to close the deliberation process and declare the unanimously chosen Nominee the Prize Laureare.  

Announcement of Laureate 

Coordination of the announcement of the Prize Laureate will be the responsibility solely of the Celiac Disease Foundation. The Prize will be officially conferred upon the Prize Laureate at the Celiac Disease Foundation Annual Research Symposium, or by similar ceremony. The Prize Laureate will be provided with two round-trip coach airfares and hotel accommodations for up to three nights and other travel-related expenses.  

In the event that the Prize Laureate dies prior to the conferral of the Prize, the Prize for that year will still bear his or her name. The monetary award will remain in the Prize endowment and will not be distributed.  

The Prize Laureate will present a lecture at the Celiac Disease Foundation Annual Research Symposium, or similar ceremony, at the time of presentation of the Prize. 

For more information, please see the Prize for Excellence in Celiac Disease Research Charter here.